Home1795 • TPE
add
Lotus Pharmaceutical Co Ltd
Previous close
$210.00
Day range
$211.50 - $215.50
Year range
$172.50 - $332.50
Market cap
57.02B TWD
Avg Volume
1.78M
P/E ratio
11.15
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 4.41B | 28.95% |
Operating expense | 1.25B | 13.37% |
Net income | 1.13B | 183.16% |
Net profit margin | 25.69 | 119.57% |
Earnings per share | 4.32 | 182.35% |
EBITDA | 1.47B | 142.10% |
Effective tax rate | 24.21% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.03B | 240.52% |
Total assets | 40.10B | 21.55% |
Total liabilities | 18.92B | 20.84% |
Total equity | 21.18B | — |
Shares outstanding | 265.39M | — |
Price to book | 2.63 | — |
Return on assets | 7.62% | — |
Return on capital | 8.73% | — |
Cash Flow
Net change in cash
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 1.13B | 183.16% |
Cash from operations | 1.55B | 11,568.35% |
Cash from investing | -523.74M | -125.08% |
Cash from financing | 1.31B | 4,658.54% |
Net change in cash | 2.34B | 932.06% |
Free cash flow | 711.50M | 463.98% |
About
Founded
1966
Website
Employees
1,099